Dr. Gueroussov is adapting CRISPR technology to make precise changes in RNA to study how genes are expressed differently in cancer cells.
Engineering CRISPR Effector Proteins for Programmable Regulation of RNA Splicing in Research and Therapeutics
Life Sciences Research Foundation - Mark Foundation Postdoctoral Fellow (2018-2019)
Serge Gueroussov, PhD, Broad Institute
Serge Gueroussov, PhD